Results 241 to 250 of about 12,546,934 (336)

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Optimizing Hearing Rehabilitation in Chronic Otitis Media: An Expert Opinion on Early Integration of Bone Conduction Devices. [PDF]

open access: yesJ Audiol Otol
Snapp HA   +13 more
europepmc   +1 more source

Adolescent-led Our Voice method to promote healthy and active lifestyles and environments in South Africa. [PDF]

open access: yesPLOS Glob Public Health
Wayas FA   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy